Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.2K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

497
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
497
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

6.1K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

786
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
786
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

1.7K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Congenital Blistering in a Newborn: Thinking Beyond Infection.

NeoReviews·2026
Same journal

An Unusual Cause of Recurrent Escherichia coli Meningitis in a Preterm Infant.

NeoReviews·2026
Same journal

Giant Omphalocele.

NeoReviews·2026
Same journal

A Pregnant Person Requiring Medical Intensive Care Unit Management of Asthma.

NeoReviews·2026
Same journal

How Would You Manage Fever in a Neonate Who Has Passed CCHD Screening?

NeoReviews·2026
Same journal

Neurodevelopmental Follow-Up of a Child With Parechovirus Meningitis: Parental Perspective and Physicians' Reflection.

NeoReviews·2026
See all related articles

Related Experiment Video

Updated: Nov 10, 2025

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

95.2K

Congenital Hyperinsulinism.

Kathryn Sims1

  • 1Pediatrix Medical Group, Dallas, TX.

Neoreviews
|April 2, 2021
PubMed
Summary
This summary is machine-generated.

Congenital hyperinsulinism (CHI) causes persistent hypoglycemia in neonates due to inappropriate insulin secretion. Early diagnosis and management, including genetic evaluation and treatment, are crucial to prevent brain injury.

More Related Videos

Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat
11:12

Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat

Published on: February 7, 2011

52.6K
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

10.6K

Related Experiment Videos

Last Updated: Nov 10, 2025

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

95.2K
Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat
11:12

Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat

Published on: February 7, 2011

52.6K
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

10.6K

Area of Science:

  • Pediatric Endocrinology
  • Medical Genetics

Background:

  • Hyperinsulinemic hypoglycemia (HH) is common in neonates, especially those born to diabetic mothers or with abnormal birth weights.
  • Immediate management involves frequent feedings or IV glucose; glucagon is an option if IV access is difficult.
  • Persistent HH warrants evaluation for congenital hyperinsulinism (CHI), a group of genetic disorders causing excessive insulin secretion.

Purpose of the Study:

  • To review the pathogenesis, genetic basis, and clinical aspects of congenital hyperinsulinism.
  • To outline diagnostic approaches and management strategies for CHI.
  • To discuss the prognosis and risk of hypoglycemic brain injury in affected infants.

Main Methods:

  • Literature review focusing on genetic defects in pancreatic beta-cell insulin secretion.
  • Analysis of clinical presentations, diagnostic criteria, and treatment modalities for CHI.
  • Examination of the impact of recurrent hypoglycemia on neurodevelopment.

Main Results:

  • CHI results from genetic defects affecting insulin secretion pathways in pancreatic beta-cells.
  • Management includes pharmacologic therapies and surgical or curative interventions.
  • Infants with CHI face significant risks of hypoglycemic brain injury due to high glucose demands of the developing brain.

Conclusions:

  • CHI is a serious genetic disorder requiring prompt diagnosis and multidisciplinary management.
  • Understanding the genetic underpinnings is key to targeted therapies and improved outcomes.
  • Preventing severe hypoglycemia is paramount to mitigate long-term neurological sequelae.